ICU治疗的COVID-19患者长期认知功能受损:一项全面对照的神经心理学研究
这项前瞻性对照队列研究在芬兰赫尔辛基大学医院和赫尔辛基大学进行,纳入213名参与者,包括ICU治疗(n=72)、病房治疗(n=49)和居家隔离(n=44)的COVID-19确诊患者,以及无COVID-19史的对照组(n=48)。急性期后6个月进行全面的神经心理学评估,计算注意力、执行功能和记忆三个域的总体认知评分。结果显示各组总体认知评分存在差异(效应量η2p=0.065,p=0.004),ICU治疗组(p=0.011)和病房治疗组(p=0.005)均差于居家隔离组;受教育年限>12年者中,ICU治疗组注意力域差于病房治疗组(p=0.021)和无COVID对照组(p=0.045);ICU治疗男性患者执行功能受损(p=0.037)。
要点
- ICU治疗COVID-19患者急性期后6个月总体认知评分差于居家隔离患者(p=0.011),病房治疗组亦差于居家隔离组(p=0.005)。
- 受教育年限>12年的ICU治疗患者注意力域评分差于病房治疗患者(p=0.021)和无COVID对照组(p=0.045)。
- ICU治疗的男性COVID-19患者执行功能域受损(p=0.037)。
- 各组总体认知评分差异效应量η2p=0.065,p=0.004,认知评估涵盖注意力、执行功能和记忆三个域。
适用人群与场景
- 2020年3月13日至12月31日期间确诊COVID-19、急性期后6个月参与全面神经心理学评估的患者,分为ICU治疗组(n=72)、病房治疗组(n=49)、居家隔离组(n=44),另设无COVID-19史对照组(n=48)。
研究设计与关键结果
- 研究类型:前瞻性对照队列研究,在赫尔辛基大学医院和赫尔辛基大学进行,共213名参与者。
- 主要终点:总体认知评分(由注意力、执行功能、记忆三个域的神经心理学测量计算)各组间存在差异,效应量η2p=0.065,p=0.004。
- ICU治疗组总体认知评分差于居家隔离组(p=0.011);病房治疗组总体认知评分差于居家隔离组(p=0.005)。
- 受教育年限>12年者中,ICU治疗组注意力域评分差于病房治疗组(p=0.021),也差于无COVID对照组(p=0.045)。
- ICU治疗的男性患者执行功能域受损(p=0.037)。
证据类型、等级与局限
- 证据类型:前瞻性对照队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与病情较轻的COVID-19患者或无COVID对照相比,ICU治疗的COVID-19患者表现出更严重的长期认知损害;受教育年限>12年者中损害尤其见于注意力域,男性则见于执行功能域。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cognitive impairment has emerged as a common post-acute sequela of coronavirus disease 2019 (COVID-19). We hypothesised that cognitive impairment exists in patients after COVID-19 and that it is most severe in patients admitted to the intensive care unit (ICU).
METHODS: This prospective controlled cohort study of 213 participants performed at the Helsinki University Hospital and the University of Helsinki, Finland, comprised three groups of patients-ICU-treated (n = 72), ward-treated (n = 49), and home-isolated (n = 44)-with confirmed COVID-19 between March 13 and December 31, 2020, participating in a comprehensive neuropsychological evaluation six months after the acute phase. Our study included a control group with no history of COVID-19 (n = 48). Medical and demographic data were collected from electronic patient records and interviews carried out four months after the acute phase. Questionnaires filled six months after the acute phase provided information about change in cognitive functioning observed by a close informant, as well as the presence of self-reported depressive and post-traumatic symptoms.
RESULTS: The groups differed (effect size η2p = 0.065, p = 0.004) in the total cognitive score, calculated from neuropsychological measures in three domains (attention, executive functions, and memory). Both ICU-treated (p = 0.011) and ward-treated patients (p = 0.005) performed worse than home-isolated patients. Among those with more than 12 years of education, ICU-treated patients performed worse in the attention domain than ward-treated patients (p = 0.021) or non-COVID controls (p = 0.045); ICU-treated male patients, in particular, were impaired in executive functions (p = 0.037).
CONCLUSIONS: ICU-treated COVID-19 patients, compared to patients with less severe acute COVID-19 or non-COVID controls, showed more severe long-term cognitive impairment. Among those with more than 12 years of education, impairment existed particularly in the domains of attention and for men, of executive functions.
TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT04864938, retrospectively registered February 9, 2021.
参考来源
- Ollila H, Pihlaja R, Koskinen S, et al. Long-term cognitive functioning is impaired in ICU-treated COVID-19 patients: a comprehensive controlled neuropsychological study. Crit Care. 2022. PMID: 35858899. doi:10.1186/s13054-022-04092-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。